Limburg PC - Search Results

1

[The hematopoietic growth factor GM-CSF in chemotherapy for ovarian carcinoma].

Biesma B, Willemse PH, Vellenga E, Limburg PC, Aalders JG, de Vries EG. Biesma B, et al. Among authors: limburg pc. Ned Tijdschr Geneeskd. 1991 Mar 9;135(10):420-4. Ned Tijdschr Geneeskd. 1991. PMID: 2020314 Clinical Trial. Dutch.

2

Effects of recombinant human interleukin-3 in patients with relapsed small-cell lung cancer treated with chemotherapy: a dose-finding study.

Postmus PE, Gietema JA, Damsma O, Biesma B, Limburg PC, Vellenga E, de Vries EG. Postmus PE, et al. Among authors: limburg pc. J Clin Oncol. 1992 Jul;10(7):1131-40. doi: 10.1200/JCO.1992.10.7.1131. J Clin Oncol. 1992. PMID: 1318953

3

Effects of interleukin-3 after chemotherapy for advanced ovarian cancer.

Biesma B, Willemse PH, Mulder NH, Sleijfer DT, Gietema JA, Mull R, Limburg PC, Bouma J, Vellenga E, de Vries EG. Biesma B, et al. Among authors: limburg pc. Blood. 1992 Sep 1;80(5):1141-8. Blood. 1992. PMID: 1515636 Free article.

4

Efficacy and tolerability of recombinant human granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related leukopenia and fever.

Biesma B, de Vries EG, Willemse PH, Sluiter WJ, Postmus PE, Limburg PC, Stern AC, Vellenga E. Biesma B, et al. Among authors: limburg pc. Eur J Cancer. 1990;26(9):932-6. doi: 10.1016/0277-5379(90)90613-x. Eur J Cancer. 1990. PMID: 2149017 Clinical Trial.

5

Flare-up of rheumatoid arthritis during GM-CSF treatment after chemotherapy.

de Vries EG, Willemse PH, Biesma B, Stern AC, Limburg PC, Vellenga E. de Vries EG, et al. Among authors: limburg pc. Lancet. 1991 Aug 24;338(8765):517-8. doi: 10.1016/0140-6736(91)90594-f. Lancet. 1991. PMID: 1678479 No abstract available.

6

Effects of recombinant human interleukin-6 in cancer patients: a phase I-II study.

van Gameren MM, Willemse PH, Mulder NH, Limburg PC, Groen HJ, Vellenga E, de Vries EG. van Gameren MM, et al. Among authors: limburg pc. Blood. 1994 Sep 1;84(5):1434-41. Blood. 1994. PMID: 8068939 Free article. Clinical Trial.

7

Potential use of recombinant human interleukin-6 in clinical oncology.

Veldhuis GJ, Willemse PH, Mulder NH, Limburg PC, De Vries EG. Veldhuis GJ, et al. Among authors: limburg pc. Leuk Lymphoma. 1996 Feb;20(5-6):373-9. doi: 10.3109/10428199609052418. Leuk Lymphoma. 1996. PMID: 8833392 Review.

8

The modulatory impact of recombinant human interleukin-6 on the immune system of cancer patients.

Nieken J, Mulder NH, Pietens J, Limburg PC, de Leij L, de Vries EG. Nieken J, et al. Among authors: limburg pc. J Immunother. 1999 Jul;22(4):363-70. doi: 10.1097/00002371-199907000-00010. J Immunother. 1999. PMID: 10404438 Clinical Trial.

9

Recombinant human interleukin-6 induces a rapid and reversible anemia in cancer patients.

Nieken J, Mulder NH, Buter J, Vellenga E, Limburg PC, Piers DA, de Vries EG. Nieken J, et al. Among authors: limburg pc. Blood. 1995 Aug 1;86(3):900-5. Blood. 1995. PMID: 7542502 Free article. Clinical Trial.

10

Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer.

Veldhuis GJ, Willemse PH, Sleijfer DT, van der Graaf WT, Groen HJ, Limburg PC, Mulder NH, de Vries EG. Veldhuis GJ, et al. Among authors: limburg pc. J Clin Oncol. 1995 Oct;13(10):2585-93. doi: 10.1200/JCO.1995.13.10.2585. J Clin Oncol. 1995. PMID: 7595711 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

211 results

Search Page

Filters